Loading clinical trials...
Loading clinical trials...
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Conditions
Interventions
Gammaplex
Locations
10
United States
Department of Medicine, University of California
Irvine, California, United States
Children's Hospital Los Angeles
Los Angeles, California, United States
IMMUNOe International Reseach Centers
Centennial, Colorado, United States
Family Allergy & Asthma Center, PC
Atlanta, Georgia, United States
Rush University Medical Center
Chicago, Illinois, United States
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania, United States
Start Date
March 1, 2011
Primary Completion Date
April 1, 2014
Completion Date
April 1, 2014
Last Updated
December 23, 2014
NCT07284641
NCT00538915
NCT00220766
Lead Sponsor
Bio Products Laboratory
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions